Is Hydroxyurea Treatment Changing the Life of Children with Sickle Cell Disease?
Background: Sickle cell disease (SCD) is a prevalent hemoglobinopathy involving sickled hemoglobin that causes multiorgan disease due to chronic recurrent vaso-occlusion and hemolysis. Fetal hemoglobin (HbF) being present showed reduction in disease severity, owing to which hydroxyurea has gained si...
Saved in:
Main Authors: | Mohammed Ali Al Sabbah, Mahmoud Radaideh, Shafeeka Mohammed Saleh, Sura Ahmed Al-Doory, Amal Mahmoud Abdalqader, Fatima Farid Mir, Aya Mohammed |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2023-07-01
|
Series: | Dubai Medical Journal |
Subjects: | |
Online Access: | https://beta.karger.com/Article/FullText/531257 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of hydroxyurea on clinical and biological parameters of sickle cell anemia in children in Abidjan
by: MIREILLE YAYO- AYE, et al.
Published: (2024-02-01) -
Sickle Cell Anemia Treatment With Hydroxyurea in Low-Resource Settings: Challenges and Opportunities for Global North-South Collaboration
by: Teresa S. Latham
Published: (2025-01-01) -
Unbinding of alpha chain of hemoglobin in sickle and normal structures
by: Jhulan Powrel, et al.
Published: (2025-01-01) -
The Validation of the sickle scan technique used to diagnose sickle cell disease
by: Magain Mihatano Barihuta, et al.
Published: (2025-01-01) -
Promising role of voxelotor in managing sickle cell disease in children: a narrative review
by: Amit Agrawal, et al.
Published: (2025-02-01)